Bombay High Court keeps company’s drug licence suspension on hold, directs FDA minister to decide on appeal by Nov 25
Times of India
Times of India
Several outlets reported this. AI can compare where they agree and differ.
Economic Times
The Hindu
The FDA pre-Deepavali inspections found violations in hygiene, food storage, manufacturing practices, and licensing requirements
Hindustan Times
The Union ministry of health and family welfare has proposed immediately suspending licences of those drug manufacturers whose products were classified as “not of standard quality” (NSQ) after failing to meet certain specified parameters
The Hindu
The FDA urged citizens to report instances of illegal drug manufacturing or sales, as well as suspected substandard drugs, medical devices and cosmetics, to its commissioner’s office or the nearest district office
Hindustan Times
The Delhi high court on Wednesday issued notice in a petition seeking directions to the Centre and its drug regulatory authorities to complete, within a stipulated time frame, the pending safety review of Ranitidine, a medication commonly used to treat acidity and reduce stomach acid